Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers
about
Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosisIn vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosisUrinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteersComparative serum bactericidal activities of three doses of ciprofloxacin administered intravenously.Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhiComparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters.Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model.Mutant selection window and characterization of allelic diversity for ciprofloxacin-resistant mutants of Rhodococcus equi.Relationship of quantitative structure and pharmacokinetics in fluoroquinolone antibacterials.Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.Cellular accumulation and activity of quinolones in ciprofloxacin-resistant J774 macrophagesEx vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers.Single-dose rufloxacin versus 3-day norfloxacin treatment of uncomplicated cystitis: clinical evaluation and pharmacodynamic considerations.Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.Management of polyomavirus-associated nephropathy in renal transplant recipients.Effect of fluoroquinolones on melanogenesis in normal human melanocytes HEMn-DP: a comparative in vitro study.
P2860
Q28344614-455C144C-E0FC-4D39-A1BE-5CCE62005EE8Q28367763-2837F648-D6AD-434E-8795-3BDF9F22FCE9Q33694071-D44F40FA-D606-46E4-9292-C6AA3C490091Q33753240-800D454F-06E0-41C5-ACAB-D9C94CA3F518Q33769931-E2554F96-5502-47B4-87BA-5B3D3ECFAA43Q33895157-ACC115A9-2DD9-42DE-8948-C9BF56169BB4Q33976236-8BC8B7ED-DC02-402A-A853-427FE1480BE2Q34045286-9DB175D0-2B11-4AE5-9F1A-91902A06E6DDQ34098582-61CB8BE7-6815-4808-BA7C-3A26AA97D518Q34509728-E0AA508F-D1D3-4027-B043-62B16FC907CEQ34648829-96C11004-72D5-4AAE-B9CF-AAEDF3DE1A5FQ35121357-5BC4A7EF-8FE5-4C64-976D-9E04A2A202EDQ35122444-03574C99-A48E-44CC-82DB-6A7F03AE38FDQ35125517-BED97AFC-7A93-468F-B452-E0F0B17F653CQ38003050-8076FF14-2647-48DA-B7F9-C105FCC08ACCQ38749316-CDC6C28D-AAB2-448B-AEDC-CBD469851640
P2860
Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Pharmacokinetics and serum bac ...... al doses in healthy volunteers
@ast
Pharmacokinetics and serum bac ...... al doses in healthy volunteers
@en
type
label
Pharmacokinetics and serum bac ...... al doses in healthy volunteers
@ast
Pharmacokinetics and serum bac ...... al doses in healthy volunteers
@en
prefLabel
Pharmacokinetics and serum bac ...... al doses in healthy volunteers
@ast
Pharmacokinetics and serum bac ...... al doses in healthy volunteers
@en
P2093
P2860
P356
P1476
Pharmacokinetics and serum bac ...... al doses in healthy volunteers
@en
P2093
P2860
P304
P356
10.1128/AAC.37.10.2193
P407
P577
1993-10-01T00:00:00Z